C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 115 filers reported holding C4 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $143,385 | -47.8% | 45,664 | -1.9% | 0.00% | – |
| Q4 2022 | $274,498 | -31.9% | 46,525 | +1.2% | 0.00% | -100.0% |
| Q3 2022 | $403,000 | +14.5% | 45,995 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $352,000 | -46.0% | 46,718 | +73.8% | 0.00% | 0.0% |
| Q1 2022 | $652,000 | -35.1% | 26,885 | -13.8% | 0.00% | 0.0% |
| Q4 2021 | $1,004,000 | -24.4% | 31,191 | +4.9% | 0.00% | -50.0% |
| Q3 2021 | $1,328,000 | -26.1% | 29,732 | -37.4% | 0.00% | 0.0% |
| Q2 2021 | $1,797,000 | +201.0% | 47,489 | +194.2% | 0.00% | +100.0% |
| Q1 2021 | $597,000 | +11.6% | 16,140 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $535,000 | – | 16,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |